References
- Chodavarapu S, Kaguni JM. Replication initiation in bacteria. Enzymes. 2016. 39: 1-30. https://doi.org/10.1016/bs.enz.2016.03.001
- Cover TL, Blaser MJ. Helicobacter pylori in health and disease. Gastroenterology. 2009. 136: 1863-1873. https://doi.org/10.1053/j.gastro.2009.01.073
- de Souza Queiroz KC, Zambuzzi WF, Santos de Souza AC, da Silva RA, Machado D, Justo GZ, Carvalho HF, Peppelenbosch MP, Ferreira CV. A possible anti-proliferative and anti-metastatic effect of irradiated riboflavin in solid tumours. Cancer Lett. 2007. 258: 126-134. https://doi.org/10.1016/j.canlet.2007.08.024
- Ghotaslou R, Leylabadlo HE, Asl YM. Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review. World J Methodol. 2015. 5: 164-174. https://doi.org/10.5662/wjm.v5.i3.164
- Hoppel CL, Tandler B. Riboflavin and mouse hepatic cell structure and function. Mitochondrial oxidative metabolism in severe deficiency states. The Journal of Nutrition. 1975. 105: 562-570. https://doi.org/10.1093/jn/105.5.562
- Joyce CM, Kelley WS, Grindley ND. Nucleotide sequence of the Escherichia coli pola gene and primary structure of DNA polymerase i. J Biol Chem. 1982. 257: 1958-1964. https://doi.org/10.1016/S0021-9258(19)68132-9
- Lee JW, Kim N, Kim JM, Nam RH, Chang H, Kim JY, Shin CM, Park YS, Lee DH, Jung HC. Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012. Helicobacter. 2013. 18: 206-214. https://doi.org/10.1111/hel.12031
- Lee MH, Cho Y, Jung BC, Kim SH, Kang YW, Pan CH, Rhee KJ, Kim YS. Parkin induces G2/M cell cycle arrest in TNF-α-treated hela cells. Biochemical and Biophysical Research Communications. 2015a. 464: 63-69. https://doi.org/10.1016/j.bbrc.2015.05.101
- Lee SW, Kim HJ, Kim JG. Treatment of Helicobacter pylori infection in korea: A systematic review and meta-analysis. J Korean Med Sci. 2015b. 30: 1001-1009. https://doi.org/10.3346/jkms.2015.30.8.1001
- Martins SA, Combs JC, Noguera G, Camacho W, Wittmann P, Walther R, Cano M, Dick J, Behrens A. Antimicrobial efficacy of riboflavin/uva combination (365 nm) in vitro for bacterial and fungal isolates: A potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci. 2008. 49: 3402-3408. https://doi.org/10.1167/iovs.07-1592
- Matnuri M, Zheng C, Sidik D, Bai G, Abdukerim M, Abdukadier A, Ahmat K, Ma Y, Eli M. Correlation analysis of riboflavin, rft2 and Helicobater pylori in gastric carcinoma. International Journal of Clinical and Experimental Pathology. 2015. 8: 13339.
- Nitharwal RG, Verma V, Dasgupta S, Dhar SK. Helicobacter pylori chromosomal DNA replication: Current status and future perspectives. FEBS Lett. 2011. 585: 7-17. https://doi.org/10.1016/j.febslet.2010.11.018
- Peek RM, Jr., Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2002. 2: 28-37. https://doi.org/10.1038/nrc703
- Powers HJ. Riboflavin (vitamin b-2) and health. Am J Clin Nutr. 2003. 77: 1352-1360. https://doi.org/10.1093/ajcn/77.6.1352
- Santos NA, Catao CS, Martins NM, Curti C, Bianchi ML, Santos AC. Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria. Arch Toxicol. 2007. 81: 495-504. https://doi.org/10.1007/s00204-006-0173-2
- Shih CK, Chen CM, Chen CY, Liu JF, Lin HW, Chou HT, Li SC. Riboflavin protects mice against liposaccharide-induced shock through expression of heat shock protein 25. Food Chem Toxicol. 2010. 48: 1913-1918. https://doi.org/10.1016/j.fct.2010.04.033
- Soni RK, Mehra P, Mukhopadhyay G, Dhar SK. Helicobacter pylori dnab helicase can bypass escherichia coli dnac function in vivo. Biochem J. 2005. 389: 541-548. https://doi.org/10.1042/BJ20050062
- Tharmalingam N, Park M, Lee MH, Woo HJ, Kim HW, Yang JY, Rhee KJ, Kim JB. Piperine treatment suppresses Helicobacter pylori toxin entry in to gastric epithelium and minimizes beta-catenin mediated oncogenesis and il-8 secretion in vitro. Am J Transl Res. 2016. 8: 885-898.
- Tu BP, Ho-Schleyer SC, Travers KJ, Weissman JS. Biochemical basis of oxidative protein folding in the endoplasmic reticulum. Science. 2000. 290: 1571-1574. https://doi.org/10.1126/science.290.5496.1571
- Woo HJ, Yang JY, Lee MH, Kim HW, Kwon HJ, Park M, Kim SK, Park SY, Kim SH, Kim JB. Inhibitory effects of β-caryophyllene on Helicobacter pylori infection in vitro and in vivo. International Journal of Molecular Sciences. 2020. 21: 1008. https://doi.org/10.3390/ijms21031008
- Wu IT, Chuah SK, Lee CH, Liang CM, Lu LS, Kuo YH, Yen YH, Hu ML, Chou YP, Yang SC, Kuo CM, Kuo CH, Chien CC, Chiang YS, Chiou SS, Hu TH, Tai WC. Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in taiwan. World J Gastroenterol. 2015. 21: 10669-10674. https://doi.org/10.3748/wjg.v21.i37.10669
- Yang JY, Lee P, Kim JB. Effect of evodiae fructus methanol extract on virulence-related genes' expression of Helicobacter pylori. Korean Journal of Clinical Laboratory Science. 2019. 51: 316-322. https://doi.org/10.15324/kjcls.2019.51.3.316
- Yeon MJ, Lee MH, Kim DH, Yang JY, Woo HJ, Kwon HJ, Moon C, Kim SH, Kim JB. Anti-inflammatory effects of kaempferol on Helicobacter pylori-induced inflammation. Bioscience, Biotechnology, and Biochemistry. 2019. 83: 166-173. https://doi.org/10.1080/09168451.2018.1528140
- Zhang YX, Zhou LY, Song ZQ, Zhang JZ, He LH, Ding Y. Primary antibiotic resistance of Helicobacter pylori strains isolated from patients with dyspeptic symptoms in beijing: A prospective serial study. World J Gastroenterol. 2015. 21: 2786-2792. https://doi.org/10.3748/wjg.v21.i9.2786
- Zhu X, Wentworth P, Kyle RA, Lerner RA, Wilson IA. Cofactor-containing antibodies: Crystal structure of the original yellow antibody. Proceedings of the National Academy of Sciences of the United States of America. 2006. 103: 3581. https://doi.org/10.1073/pnas.0600251103